|IDSA Advocacy Update: Animal Drug Legislation Passes|
month passed legislation requiring drug manufacturers to report to the Food and
Drug Administration (FDA) the quantities of antibiotics sold for use in food
animals. IDSA was a primary supporter of the provision, found in the Animal Drug
User Fee Amendments of 2008. The
provision provides an important step toward better understanding the amounts of
antibiotics used in food animals, with the end goal of limiting any negative
impacts of such use on human health.
Other advocacy efforts include:
- The Society asked the FDA to clarify whether the Orphan Drug (OD) Act or a parallel regulatory framework would be an appropriate mechanism to spur research and development of antibacterial therapies and related diagnostics and vaccines for drug-resistant infections. Previous conflicting comments from FDA officials have caused confusion for policymakers trying to address the problems outlined in IDSA’s 2004 “Bad Bugs, No Drugs” report.
- IDSA issued a press release opposing the Environmental Protection Agency’s decision to permit the State of
Michigan to spray the state’s apple orchards with gentamicin. The Society said this decision risks undermining the value of this important antibiotic to treat blood infections in newborns and other serious human infections.
< Previous Article | Next Article >